/Companies

Tandem Tx

1 known investors

Find your way into Tandem Tx

Sign up to find every way you can get introduced to Tandem Tx

  • Your email: who you already know at Tandem Tx, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Tandem Tx team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

TANDEM Therapeutics is an early-stage biopharmaceutical company developing precision therapies for fibrosis and fibrotic cancers using Matrix Targeting Peptides that address disease-associated extracellular matrix alterations. Its pipeline of conditionally targeted therapies is based on research from ETH Zürich and the Paul Scherrer Institute in matrix mechanobiology.

Founders & leadership

MC
Mamta ChabriaCofounder
VV
Viola VogelCofounder
MB
Martin BeheCofounder

Investors · 1

Frequently asked questions

What does Tandem Tx do?
TANDEM Therapeutics is an early-stage biopharmaceutical company developing precision therapies for fibrosis and fibrotic cancers using Matrix Targeting Peptides that address disease-associated extracellular matrix alterations. Its pipeline of conditionally targeted therapies is based on research from ETH Zürich and the Paul Scherrer Institute in matrix mechanobiology.
Who founded Tandem Tx?
Tandem Tx was founded by Mamta Chabria, Viola Vogel, Martin Behe.
Who are Tandem Tx's investors?
Tandem Tx's investors include Kickfund.